Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 101 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1001 11.5 months NSCLC 4 Biologic therapy
Chemotherapy
Kantonsspital St.Gallen Switzerland 4/2008
Treatment Details: Patients: This study involved 63 non-small-cell lung cancer patients who had not received prior chemotherapy. The median age was 62 years and 62% were male. Treatment: Patients were tr
 
1002 11.5 months Advanced or metastatic breast cancer 5 Chemotherapy
Baylor-Sammons Cancer Center United States 6/2002
Treatment Details: Patients: This Phase III study involved 511 women with metastatic breast cancer or breast cancer that was unresectable and locally advanced. Patients were divided into two groups: Group A c
 
1003 11.5 months Stage III non-small-cell lung cancer 5 Chemotherapy
Galician Lung Cancer Group Spain 5/2003
Treatment Details: Patients: This study involved 46 patients with stage III non-small-cell lung cancer who had not received prior chemotherapy. The median age of the patients was 63.5 years old. Treatment:
 
1004 11.4 months Hormone-refractory metastatic prostate cancer 4 Chemotherapy
Leon Berard France 8/2003
Treatment Details: Patients: This Phase II randomized study involved 54 patients with hormone refractory metastatic prostate cancer. Patients were divided into two groups: Group 1 with 26 patients and Group 2
 
1005 11.4 months Hepatocellular carcinoma 5 Biologic therapy
The University of Texas M. D. Anderson Cancer Center United States 5/2010
Treatment Details: Patients: This phase II study involved 80 patients with hepatocellular carcinoma, 86.3% of whom were male. The median patient age was 68 years. Treatment: Patients were treated with th
 
1006 11.4 months Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma 4 Chemotherapy
University of Texas Southwestern Medical Center United States 3/2009
Treatment Details: Patients: This phase 2 study involved fifty-one women with recurrent or persistent platinum-resistant ovarian or primary peritoneal cancer. The majority were between the ages of 40 and 79.
 
1007 11.4 months Liver Cancer 5 Biologic therapy
Chemotherapy
Zhejiang Cancer Hospital China 11/2014
Treatment Details: Patients: This study involved 75 hepatocellular carcinoma patients who had not received prior chemotherapy. The median patient age was 51.3 years and 86.7% were male. Treatment: Patien
 
1008 11.4 months Metastatic colorecal cancer 2 Biologic therapy
Catharina Hospital Eindhoven Netherlands 11/2013
Treatment Details: Patients: This study involved 31 metastatic colorectal cancer patients who had previously received fluoropyrimidine-based chemotherapy. The average patient age was 65.5 years and 58.1% wer
 
1009 11.4 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
Albert Einstein Cancer Center United States 7/2012
Treatment Details: Patients: This phase 2 study involved 63 female taxane-resistant metastatic breast cancer patients who had been previously treated with anthracyclines. The median patient age was 52 years.
 
1010 11.4 months HER2-negative advanced breast cancer 5 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 5/2013
Treatment Details: Patients: This phase 2 study involved female HER2-negative advanced breast cancer patients previously treated with bevacizumab who were divided into two separate treatment groups patients.
 
Page 101 of 187  | Previous Page  | Next Page